Know a great AI tool or AI news source? Submit it to AiByts
Health2 min read

Millions of Americans are not taking their GLP-1 drugs as prescribed

Cost and access barriers are pushing people to modified use and unapproved versions.

By Beth MoleArs Technica
Millions of Americans are not taking their GLP-1 drugs as prescribed

Read the full story

Originally published by Ars Technica on Nov 13, 2026.

Read on Ars Technica(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.